EWTX
Price
$26.26
Change
-$0.46 (-1.72%)
Updated
Jan 17 closing price
Capitalization
2.49B
32 days until earnings call
OPORF
Price
$0.28
Change
-$0.09 (-24.32%)
Updated
Jan 6 closing price
Capitalization
150.67M
Ad is loading...

EWTX vs OPORF

Header iconEWTX vs OPORF Comparison
Open Charts EWTX vs OPORFBanner chart's image
Edgewise Therapeutics
Price$26.26
Change-$0.46 (-1.72%)
Volume$589.4K
Capitalization2.49B
OPEN ORPHAN
Price$0.28
Change-$0.09 (-24.32%)
Volume$3K
Capitalization150.67M
EWTX vs OPORF Comparison Chart
Loading...
EWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPORF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EWTX vs. OPORF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWTX is a Hold and OPORF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (EWTX: $26.26 vs. OPORF: $0.28)
Brand notoriety: EWTX and OPORF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EWTX: 71% vs. OPORF: 409%
Market capitalization -- EWTX: $2.49B vs. OPORF: $150.67M
EWTX [@Biotechnology] is valued at $2.49B. OPORF’s [@Biotechnology] market capitalization is $150.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EWTX’s FA Score shows that 1 FA rating(s) are green whileOPORF’s FA Score has 2 green FA rating(s).

  • EWTX’s FA Score: 1 green, 4 red.
  • OPORF’s FA Score: 2 green, 3 red.
According to our system of comparison, EWTX is a better buy in the long-term than OPORF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EWTX’s TA Score shows that 3 TA indicator(s) are bullish while OPORF’s TA Score has 1 bullish TA indicator(s).

  • EWTX’s TA Score: 3 bullish, 3 bearish.
  • OPORF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, OPORF is a better buy in the short-term than EWTX.

Price Growth

EWTX (@Biotechnology) experienced а +8.74% price change this week, while OPORF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

EWTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EWTX($2.49B) has a higher market cap than OPORF($151M). EWTX YTD gains are higher at: -1.648 vs. OPORF (-24.749). OPORF has higher annual earnings (EBITDA): 14M vs. EWTX (-144.96M). OPORF has higher revenues than EWTX: OPORF (56M) vs EWTX (0).
EWTXOPORFEWTX / OPORF
Capitalization2.49B151M1,647%
EBITDA-144.96M14M-1,035%
Gain YTD-1.648-24.7497%
P/E RatioN/A8.96-
Revenue056M-
Total Cash493MN/A-
Total Debt4.44MN/A-
TECHNICAL ANALYSIS
Technical Analysis
EWTXOPORF
RSI
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 12 days ago
33%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 12 days ago
83%
N/A
MACD
ODDS (%)
Bearish Trend 12 days ago
74%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
N/A
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
24%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
88%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
EWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPORF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NIAGX12.520.07
+0.56%
Nia Impact Solutions
RNWHX76.840.35
+0.46%
American Funds New World R5E
EQIDX11.860.05
+0.42%
Allspring Emerging Markets Eq Advtg Adm
MRRGX37.000.15
+0.41%
Meridian Growth Institutional
PRUZX15.760.01
+0.06%
PGIM Jennison Utility Z

EWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EWTX has been loosely correlated with ATXS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EWTX jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EWTX
1D Price
Change %
EWTX100%
-1.72%
ATXS - EWTX
37%
Loosely correlated
-3.23%
RVMD - EWTX
35%
Loosely correlated
+0.98%
VIR - EWTX
33%
Loosely correlated
+0.60%
AXON - EWTX
33%
Loosely correlated
+1.37%
SVRA - EWTX
33%
Loosely correlated
+0.69%
More

OPORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPORF has been loosely correlated with YMAB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OPORF jumps, then YMAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPORF
1D Price
Change %
OPORF100%
N/A
YMAB - OPORF
34%
Loosely correlated
-0.32%
ENTX - OPORF
31%
Poorly correlated
+4.93%
PMN - OPORF
23%
Poorly correlated
-2.19%
EWTX - OPORF
6%
Poorly correlated
-1.72%
BCTX - OPORF
4%
Poorly correlated
-1.82%
More